Assessing Disability in Thalassaemia: A Position Statement by the Thalassaemia International Federation

IF 2.3 3区 医学 Q2 HEMATOLOGY
Dimitrios Farmakis, Michael Angastiniotis, Georgios Papingiotis, Lily Cannon, Androulla Eleftheriou
{"title":"Assessing Disability in Thalassaemia: A Position Statement by the Thalassaemia International Federation","authors":"Dimitrios Farmakis,&nbsp;Michael Angastiniotis,&nbsp;Georgios Papingiotis,&nbsp;Lily Cannon,&nbsp;Androulla Eleftheriou","doi":"10.1111/ejh.14367","DOIUrl":null,"url":null,"abstract":"<p>Thalassemia is not currently conceived per se as a disability, but it can be a disability-inducing condition if poorly treated or as complications increase with age. People living with thalassemia do not wish, on the one hand, to be considered disabled persons to avoid stigma and loss of opportunities to achieve social inclusion in all paths of life while, on the other, they are in need of lifelong appropriate, disease-specific health and social care, including disability allowances and schemes, in order to be able to smoothly integrate into society and achieve professional, educational, personal, and social goals. The ongoing debate on whether thalassemia is a disability or not is thus complex and inconclusive and has created a vast heterogeneity of policies and approaches across the globe. Given that the risk to develop disabilities is subject to individualised assessment, the thalassemia International Federation (TIF) proposes a specific disability risk assessment model for thalassaemia (DRAM-Thal), based on the findings of a targeted literature review and of the TIF survey 2022–2023. This model considers both clinical features and social parameters and is addressed to national healthcare and social services and all other relevant stakeholders. At the same time, this work prompts further research on this understudied topic that heavily affects the rights and daily life of people living with the disease.</p>","PeriodicalId":11955,"journal":{"name":"European Journal of Haematology","volume":"114 3","pages":"411-422"},"PeriodicalIF":2.3000,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ejh.14367","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ejh.14367","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Thalassemia is not currently conceived per se as a disability, but it can be a disability-inducing condition if poorly treated or as complications increase with age. People living with thalassemia do not wish, on the one hand, to be considered disabled persons to avoid stigma and loss of opportunities to achieve social inclusion in all paths of life while, on the other, they are in need of lifelong appropriate, disease-specific health and social care, including disability allowances and schemes, in order to be able to smoothly integrate into society and achieve professional, educational, personal, and social goals. The ongoing debate on whether thalassemia is a disability or not is thus complex and inconclusive and has created a vast heterogeneity of policies and approaches across the globe. Given that the risk to develop disabilities is subject to individualised assessment, the thalassemia International Federation (TIF) proposes a specific disability risk assessment model for thalassaemia (DRAM-Thal), based on the findings of a targeted literature review and of the TIF survey 2022–2023. This model considers both clinical features and social parameters and is addressed to national healthcare and social services and all other relevant stakeholders. At the same time, this work prompts further research on this understudied topic that heavily affects the rights and daily life of people living with the disease.

Abstract Image

评估地中海贫血的残疾:地中海贫血国际联合会的立场声明。
地中海贫血目前本身并不被认为是一种残疾,但如果治疗不当或随着年龄的增长并发症增加,地中海贫血可能会导致残疾。地中海贫血患者一方面不希望被视为残疾人,以避免污名化和失去在生活的所有道路上实现社会融入的机会,另一方面,他们需要终身适当的、针对疾病的保健和社会护理,包括残疾津贴和计划,以便能够顺利融入社会,实现专业、教育、个人和社会目标。因此,正在进行的关于地中海贫血是否是一种残疾的辩论既复杂又没有定论,并在全球范围内造成了政策和方法的巨大差异。鉴于发展为残疾的风险需要进行个体化评估,地中海贫血国际联合会(TIF)基于一项有针对性的文献综述和TIF 2022-2023年调查的结果,提出了地中海贫血的特定残疾风险评估模型(dam - thal)。该模型考虑了临床特征和社会参数,并针对国家保健和社会服务以及所有其他相关利益攸关方。与此同时,这项工作促进了对这一未被充分研究的主题的进一步研究,这一主题严重影响了疾病患者的权利和日常生活。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.50
自引率
0.00%
发文量
168
审稿时长
4-8 weeks
期刊介绍: European Journal of Haematology is an international journal for communication of basic and clinical research in haematology. The journal welcomes manuscripts on molecular, cellular and clinical research on diseases of the blood, vascular and lymphatic tissue, and on basic molecular and cellular research related to normal development and function of the blood, vascular and lymphatic tissue. The journal also welcomes reviews on clinical haematology and basic research, case reports, and clinical pictures.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信